title: Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.
abstract: OBJECTIVE
  To determine whether efflux systems contribute to multidrug resistance of H pylori.
  
  
  METHODS
  A chloramphenicol-induced multidrug resistance model of six susceptible H pylori strains (5 isolates and H pylori NCTC11637) was developed. Multidrug-resistant (MDR) strains were selected and the minimal inhibitory concentration (MIC) of erythromycin, metronidazole, penicillin G, tetracycline, and ciprofloxacin in multidrug resistant strains and their parent strains was determined by agar dilution tests. The level of mRNA expression of hefA was assessed by fluorescence real-time quantitative PCR. A H pylori LZ1026 knockout mutant (delta H pylori LZ1026) for (putative) efflux protein was constructed by inserting the kanamycin resistance cassette from pEGFP-N2 into hefA, and its susceptibility profiles to 10 antibiotics were evaluated.
  
  
  RESULTS
  The MIC of six multidrug-resistant strains (including 5 clinical isolates and H pylori NCTC11637) increased significantly (>or=4-fold) compared with their parent strains. The expression level of hefA gene was significantly higher in the MDR strains than in their parent strains (P=0.033). A H pylori LZ1026 mutant was successfully constructed and the delta H pylori LZ1026 was more susceptible to four of the 10 antibiotics. All the 20 strains displayed transcripts for hefA that confirmed the in vitro expression of these genes.
  
  
  CONCLUSIONS
  The efflux pump gene hefA plays an important role in multidrug resistance of H pylori.
authors.affiliation: Department of Gastroenterology, the Second Affiliated Hospital of Zhengzhou University, 2 Jingba Road, Zhengzhou 450014, Henan Province, China.
authors.forename: Zhi-Qiang
authors.initials: ZQ
authors.lastname: Liu
authors.forename: Peng-Yuan
authors.initials: PY
authors.lastname: Zheng
authors.forename: Ping-Chang
authors.initials: PC
authors.lastname: Yang
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D002939:Ciprofloxacin / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000187:drug effects / Q000235:genetics* / Q000502:physiology*; D004917:Erythromycin / Q000494:pharmacology; D005798:Genes, Bacterial / Q000235:genetics*; D019450:Genes, MDR / Q000235:genetics*; D016480:Helicobacter pylori / Q000187:drug effects / Q000235:genetics* / Q000502:physiology*; D008795:Metronidazole / Q000494:pharmacology; D009154:Mutation / Q000502:physiology; D010400:Penicillin G / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D013752:Tetracycline / Q000494:pharmacology
chemical_list: D018435:ATP Binding Cassette Transporter, Subfamily B; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D012333:RNA, Messenger; D008795:Metronidazole; D002939:Ciprofloxacin; D004917:Erythromycin; D013752:Tetracycline; D010400:Penicillin G
references.citation: Antimicrob Agents Chemother. 2005 Jul;49(7):3009-10
references.pmid: 15980386
references.citation: J Microbiol Biotechnol. 2007 Sep;17(9):1460-8
references.pmid: 18062223
references.citation: Glycobiology. 2000 Jul;10(7):701-13
references.pmid: 10910974
references.citation: J Mol Microbiol Biotechnol. 2001 Apr;3(2):145-50
references.pmid: 11321566
references.citation: Mol Microbiol. 1994 Mar;11(5):841-7
references.pmid: 8022262
references.citation: Microb Drug Resist. 2002 Winter;8(4):281-9
references.pmid: 12523625
references.citation: World J Gastroenterol. 2003 Oct;9(10):2251-7
references.pmid: 14562387
references.citation: J Bacteriol. 2005 Aug;187(15):5341-6
references.pmid: 16030228
references.citation: Microbiol Mol Biol Rev. 2000 Dec;64(4):672-93
references.pmid: 11104814
references.citation: Helicobacter. 2004;9 Suppl 1:67-72
references.pmid: 15347308
references.citation: J Mol Biol. 1999 Apr 2;287(3):695-715
references.pmid: 10092468
references.citation: FEMS Microbiol Lett. 2002 Oct 8;215(2):279-83
references.pmid: 12399047
references.citation: J Appl Microbiol. 2007 Nov;103(5):1931-41
references.pmid: 17953603
references.citation: Antimicrob Agents Chemother. 2005 Apr;49(4):1477-82
references.pmid: 15793129
references.citation: Lancet. 1984 Jun 16;1(8390):1311-5
references.pmid: 6145023
references.citation: Helicobacter. 2007 Oct;12 Suppl 1:31-7
references.pmid: 17727458
references.citation: J Bacteriol. 2007 Aug;189(15):5550-8
references.pmid: 17526713
references.citation: Trends Microbiol. 2001 Feb;9(2):71-9
references.pmid: 11173246
references.citation: Clin Infect Dis. 1998 Aug;27 Suppl 1:S32-41
references.pmid: 9710669
references.citation: Antimicrob Agents Chemother. 2000 Feb;44(2):248-54
references.pmid: 10639345
references.citation: Appl Environ Microbiol. 2004 Feb;70(2):693-703
references.pmid: 14766544
references.citation: J Bacteriol. 1996 Jul;178(13):3791-5
references.pmid: 8682782
references.citation: Plasmid. 2001 Jan;45(1):37-40
references.pmid: 11319930
references.citation: Curr Opin Gastroenterol. 2005 Jan;21(1):32-8
references.pmid: 15687882
references.citation: BMC Mol Biol. 2007 Aug 15;8:67
references.pmid: 17697375
references.citation: Antimicrob Agents Chemother. 2005 Nov;49(11):4635-40
references.pmid: 16251306
references.citation: Antimicrob Agents Chemother. 2006 Jun;50(6):1913-20
references.pmid: 16723545
references.citation: Infection. 1994;22 Suppl 2:S105-10
references.pmid: 7927828
references.citation: FEBS Lett. 2003 Nov 27;555(1):66-71
references.pmid: 14630321
references.citation: Gut. 2007 Jun;56(6):772-81
references.pmid: 17170018